Quick Answer
Beneficient reported Total Revenue of -$7.94 million for the year ending 2025.
- Beneficient showed an increase of +92.0% in Total Revenue from 2024 to 2025.
- This data is from Beneficient's annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2020 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $2.36 million | Q1 2022: -$66.62 million | Q2 2022: -$37.04 million | Q3 2022: -$37.95 million | Q4 2022: -$11.44 million | Q2 2023: -$2.74 million | Q3 2023: -$42.76 million | Q4 2023: -$10.24 million | Q2 2024: $10.05 million | Q3 2024: $8.56 million | Q4 2024: $4.42 million | Q2 2025: -$12.62 million | Q3 2025: -$2.76 million | Q4 2025: $18.67 million.
- Over the full 5 years of available data (2020 to 2025), Beneficient's Total Revenue has declined by 105.7%.
- Historical annual values: Fiscal year 2025: -$7.94 million | Fiscal year 2024: -$98.70 million | Fiscal year 2023: -$104.90 million | Fiscal year 2021: $55.31 million | Fiscal year 2020: $140.33 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: